Company Profile

Chosen Diagnostics Inc
Profile last edited on: 1/18/2022      CAGE: 7XHB7      UEI: C67UDPUEB6D3

Business Identifier: Diagnostic biomarkers: improving health care delivery for patients by personalizing their medicine
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1441 Canal Street
New Orleans, LA 70112
   (504) 680-2973
Location: Single
Congr. District: 02
County: Orleans Parish

Public Profile

Spun out of the School of Medicine at LSU Health New Orleans, Chosen Diagnostics is a health care delivery company structured around development of two novel biomarker diagnostic kits. The first of those kits is focused on a common gastrointestinal disease in premature infants - a biomarker test to diagnose a common and life-threatening bowel disease in preterm infants offering more accurate results than current options and allows earlier medical intervention. The second is a diagnostic kit to assess how likely a patient is to respond to certain drug treatments. Management indicate the firm's objective as being to improve the delivery of effective health care by directly addressing the personalization of medicines prescribed for - and being used by - the patient.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 NIH $2,347,370
Project Title: Noninvasive Biomarkers for Gastrointestinal Disease in Preterm Infants
2020 1 NSF $224,758
Project Title: Absolute protein quantitation in in vitro diagnostics for gut inflammation

Key People / Management

  Sunyoung Kim -- President and CEO

  Rebecca S Buckley -- COO